Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Amplia Therapeutics ( (AU:ATX) ) is now available.
Amplia Therapeutics Limited has announced the quotation of 96,804,354 fully paid ordinary securities on the Australian Securities Exchange as of July 29, 2025. This move is part of previously announced transactions and could potentially enhance the company’s market presence and liquidity, benefiting stakeholders by increasing the company’s visibility and access to capital.
More about Amplia Therapeutics
Amplia Therapeutics Limited is a company operating in the biotechnology industry, focusing on the development and commercialization of therapeutic products. The company is listed on the Australian Securities Exchange under the code ATX.
Average Trading Volume: 6,873,508
Technical Sentiment Signal: Buy
Current Market Cap: A$95.47M
For an in-depth examination of ATX stock, go to TipRanks’ Overview page.